Immune reactions associated with practolol therapy.
A review of adverse reactions following practolol therapy is presented. The appearance of antinuclear antibodies seems to herald the clinical manifestations. Antinuclear antibodies were found in 30% of patients treated with practolol for prolonged periods. It is suggested that patients who develop an immune reaction following practolol metabolize the drug differently than those who do not.